Navigation Links
Inhibikase Therapeutics to present at 5th International Congress on Polyomaviruses and Human Diseases
Date:4/25/2013

ATLANTA, April 25, 2013 /PRNewswire/ -- Inhibikase Therapeutics, Inc., an emerging leader in infectious disease, announced today that it will update the scientific and medical community on the development program for IkT-001Pro.  IkT-001Pro, a host-directed tyrosine kinase inhibitor in an extended release formulation, is intended to clear JC polyomavirus (JCV) infection, the causative agent of Progressive Multifocal Leukoencephalopathy (PML).  The Company will demonstrate the effectiveness of IkT-001Pro against patient-derived JCV isolated from the urine of patients chronically infected with virus, the first time a direct measure of antiviral potency against patient-derived virus has been possible.  A preliminary insight into clinical efficacy of the proposed therapy will also be presented, linking mechanism of action to direct control of virus in patients.  

(Logo: http://photos.prnewswire.com/prnh/20110517/CL02791LOGO)

JCV infection progresses to PML only in patients with chronic or drug-induced immune suppression, to include patients diagnosed with clinical AIDS or who are receiving monoclonal antibody treatment for MS, lupus, rheumatoid arthritis, leukemia or lymphoma.   IkT-001Pro is projected to clear the patient of chronic JCV infection prior to its transformation and entry into the brain, thereby acting as a form of preventative therapy for AIDS patients and/or patients on immunosuppressive therapy.

"The ability to isolate and replicate patient-derived virus and demonstrate antiviral potency for IkT-001Pro validates the mechanism of action of this medication against the viral infection that actually afflicts patients.  Combined with a preliminary clinical readout, Inhibikase may have found a path to control the PML development in at least some patients.  While further clinical evaluati
'/>"/>

SOURCE Inhibikase Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Immunomic Therapeutics Announces Interim Data Analysis of Phase I Study to Treat Japanese Red Cedar Allergy
2. PTC Therapeutics Appoints Mark Rothera As Chief Commercial Officer
3. DSM and DecImmune Therapeutics Sign Agreement to Develop N2 Pathway Blocking Antibody
4. Serina Therapeutics Announces Agreement Retaining Woodside Capital Partners as Advisor and Investment Bank
5. Serina Therapeutics Announces Worldwide Exclusive License Agreement with The Scripps Research Institute for Click Chemistry
6. Mast Therapeutics Presents MST-188 Data at 7Th Annual Sickle Cell Disease Research and Educational Symposium
7. Society for Brain Mapping and Therapeutics (SBMT) announce the formation of American Board of Brain Mapping, its 2013 award recipients and its Brain Mapping Day at the US Congress
8. Sorbent Therapeutics Initiates Phase 2b Clinical Trial of CLP-1001 for Treatment of Signs and Symptoms of Fluid Overload in Patients with Heart Failure
9. NewGen Therapeutics Presents Data on NT-113, A Novel Pan-ErbB Inhibitor, at American Association of Cancer Research
10. Sorrento Therapeutics, Inc. and IGDRASOL Announce Presentation on Non-Biologic Nanoparticle paclitaxel (NBN-Pac) Formulations for the Treatment of Solid Tumors at the Nanomedicine 2013 Meeting in Barcelona, Spain
11. Spencer Trask Congratulates InVivo Therapeutics on its Recent Approvals from the FDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... , March 26, 2015 InfuSystem Holdings, Inc. ... and related services for the healthcare industry in ... , announced today it has secured a new $45.0 million ... its previous $36.5 million credit facility with its prior lender ... entered into the new five-year senior secured credit agreement comprised ...
(Date:3/26/2015)... , 26. März 2015  Die National ... vom 1. April 2015 an Zulassungsanträge für Domainnamen ... Apotheken annehmen. Seit dem Start des .Pharmacy ... über 275 .pharmacy-Domainnamen zugelassen, die für die ... beantragt wurden. Die NABP startete .pharmacy TLD, ...
(Date:3/26/2015)... Editor Note: For more information about ... Investor-Edge has initiated coverage on the following equities: Mylan ... SLXP ), Hospira Inc. (NYSE: HSP ), ... (NASDAQ: AKRX ). Free research report on Mylan ... markets declined on Wednesday, March 25, 2015, as the ...
Breaking Medicine Technology:InfuSystem Announces New $45 Million Credit Facility At Substantially Lower Rates 2InfuSystem Announces New $45 Million Credit Facility At Substantially Lower Rates 3InfuSystem Announces New $45 Million Credit Facility At Substantially Lower Rates 4Alle abgebenden Apotheken berechtigt, um ab dem 1. April 2015 .Pharmacy-Domainnamen zu beantragen 2Active Equities to Watch in the Pharma Industry -- Mylan, Salix Pharma, Hospira, VIVUS, and Akorn 2Active Equities to Watch in the Pharma Industry -- Mylan, Salix Pharma, Hospira, VIVUS, and Akorn 3Active Equities to Watch in the Pharma Industry -- Mylan, Salix Pharma, Hospira, VIVUS, and Akorn 4Active Equities to Watch in the Pharma Industry -- Mylan, Salix Pharma, Hospira, VIVUS, and Akorn 5
... Valeant Pharmaceuticals International, Inc. (NYSE: VRX ) ... company completed its previously announced acquisition of AB Sanitas ... Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) ... and markets a broad range of pharmaceutical products primarily ...
... Medical Inc. (NYSE: SMA ), a leading ... implants, surgical instruments, and sterilization cases and trays, announced ... of Olsen Medical. Olsen Medical is a ... of electrosurgical instruments and accessories. It manufactures a full ...
Cached Medicine Technology:Symmetry Medical Closes Olsen Medical Acquisition 2
(Date:3/26/2015)... New York (PRWEB) March 26, 2015 ... to move forward nationwide, with the issuance of ... in Pennsylvania and Louisiana. According to an Order ... multidistrict litigation established for Xarelto injury claims in ... will now allow plaintiffs to file cases directly ...
(Date:3/26/2015)... 2015 “The SWEET Act is an important ... more available and help parents who are working to reduce ... reasonable approach to support public health, and we will continue ... the health of all families,” said Dr. Jane Delgado President ... the introduction of the Sugar-Sweetened Beverage Tax (SWEET) Act by ...
(Date:3/26/2015)... Frencisco, CA (PRWEB) March 26, 2015 ... Center are proud to announce expanded offerings for Bay ... San Francisco Dental Implant Center has long been a ... have expanded its offerings to meet the strong demand ... in our reputation as a top-rated dental implant facility ...
(Date:3/26/2015)... Altamonte Springs, FL (PRWEB) March 26, 2015 ... one of the nation’s leading innovative specialty pharmacies, ... newly created position of Vice President of Pharmaceutical ... for fostering beneficial connections with our pharmaceuticals partners ... pharmaceutical relationships in support of BioPlus’ expansion. ...
(Date:3/26/2015)... In the key developed markets, the hypertension market ... set to decrease through 2020 at a negative CAGR (0.9%) ... up to 2017 at a 2.6% CAGR and a decline ... the surging penetration of fixed-dose combination drugs like Azor, Amturnide, ... HCT, and Tekamlo), a hike in the prevalence population to ...
Breaking Medicine News(10 mins):Health News:Xarelto Lawsuits Move Forward Nationwide, With Issuance of New Court Docs in State, Federal Litigations 2Health News:Xarelto Lawsuits Move Forward Nationwide, With Issuance of New Court Docs in State, Federal Litigations 3Health News:National Alliance for Hispanic Health Statement on Introduction of SWEET Act in 114th Congress 2Health News:Bay Area Dental Implant Specialist, Dr. Alex Rabinovich Announces Regional Educational Strategy 2Health News:Bay Area Dental Implant Specialist, Dr. Alex Rabinovich Announces Regional Educational Strategy 3Health News:BioPlus Specialty Pharmacy Expands Executive Team with New Position, Naming Sharon Ferrer as Vice President of Pharmaceutical Relations 2Health News:Top 8 Developed Anti-Hypertensive Therapeutics Markets Discussed in New GBI Research Report Published at MarketPublishers.com 2Health News:Top 8 Developed Anti-Hypertensive Therapeutics Markets Discussed in New GBI Research Report Published at MarketPublishers.com 3
... FRIDAY, July 8 (HealthDay News) -- Obese people who ... to suffer from complications than those of normal weight, ... are often used by insurance companies, the Johns Hopkins ... and hospitals are reimbursed for more complex procedures or ...
... As any student who,s had to study for multiple exams ... facts one after another is challenging. As you study for ... the history exam is forgotten. It,s been widely believed that ... have the capacity necessary to process both memories in quick ...
... By Steven Reinberg HealthDay Reporter , THURSDAY, July ... threatens America,s future reveals that obesity rates climbed over the ... reported a decline in the proportion of excessively overweight residents. ... 30 percent of the people in 12 states are obese. ...
... analysis of heart disease and stroke statistics collected in 192 ... relative burden of the two diseases varies widely from country ... to researchers at the University of California, San Francisco. ... UCSF scientists found that developing countries tend to suffer more ...
... at the Neglected Tropical Diseases Meeting of the International ... for Neglected Diseases initiative (DNDi) announced the first research ... portfolio to address unmet needs of patients in Africa ... potential of the drug flubendazole to treat a highly ...
... (HealthDay News) -- It is well-known that smoking is unhealthy, ... require total hip or knee replacement, according to a new ... doing vigorous physical activity increased the likelihood of joint replacement. ... of 11,388 men who were followed from 1996-1999 to March ...
Cached Medicine News:Health News:Obesity May Increase Risk of Surgical Complications 2Health News:Study demonstrates how memory can be preserved -- and forgetting prevented 2Health News:U.S. Obesity Epidemic Continues to Spread 2Health News:U.S. Obesity Epidemic Continues to Spread 3Health News:Heart disease and stroke worldwide tied to national income 2Health News:DNDi expands activities to neglected patient needs in the field of helminth infections 2Health News:DNDi expands activities to neglected patient needs in the field of helminth infections 3Health News:Men Who Smoke at Lower Risk of Joint Replacement: Study 2
... chairs with concave seats and standard-sized ... options like seats, backrests, armrests, and ... are recommended for the following environments: ... control, health care and office. • ...
... ergonomic chairs with concave seats and ... Select options like seats, backrests, armrests, ... chairs are recommended for the following ... static control, health care and office. ...
... Basic ergonomic chairs with concave seats ... • Select options like seats, backrests, ... BTN/1Q-CAB chairs are recommended for the ... room, static control, health care and ...
... Basic ergonomic chairs with concave ... support • Select options like seats, ... • BTN/1Q-CAB chairs are recommended for ... clean room, static control, health care ...
Medicine Products: